19-Dec-2025
Howard Hughes Shifts Gears, Buys Vantage In $2.1 Billion Insurance Move
Benzinga (Thu, 18-Dec 2:00 PM ET)
M&A News: Howard Hughes Stock (HHH) Pops as Ackman Mirrors Buffett in $2.1B Vantage Group Deal
TipRanks (Thu, 18-Dec 12:00 PM ET)
Vantage Group Holdings to be acquired by Howard Hughes Holdings
PRNewswire (Thu, 18-Dec 6:13 AM ET)
Medline (MDLN) Opens Trading with a Boom, Marks 2025’s Biggest IPO
TipRanks (Wed, 17-Dec 4:13 PM ET)
Globe Newswire (Wed, 17-Dec 9:33 AM ET)
Johnson & Johnson Rival Medline Pulls Off $6B IPO, Topping 2025 Deal Table
TipRanks (Wed, 17-Dec 6:16 AM ET)
Johnson & Johnson Rival Medline Pulls Off $6B-Plus IPO, Topping 2025 Deal Table
TipRanks (Wed, 17-Dec 6:16 AM ET)
Medline reportedly guiding IPO at upper half of price range
Seeking Alpha News (Tue, 16-Dec 10:42 AM ET)
Acentra Health Named to Northern Virginia Technology Council's Tech100
Globe Newswire (Mon, 15-Dec 10:55 PM ET)
Acentra Health Names Patty Obermaier as Chief Growth Officer
Globe Newswire (Thu, 11-Dec 9:32 AM ET)
Carlyle Group is one of the world's largest alternative-asset managers, with $474.1 billion in total AUM, including $332.0 billion in fee-earning AUM, at the end of September 2025. The company has three core business segments: global private equity, which includes its private equity, real estate, infrastructure, and natural resources offerings (with $163.5 billion in total AUM and $101.1 billion in fee-earning AUM), global credit ($208.5 billion/$167.2 billion), and investment/fund solutions, known as Carlyle AlphInvest ($102.1 billion/$63.7 billion). The firm primarily serves institutional investors and high-net-worth individuals. Carlyle operates through 29 offices across five continents, serving more than 3,100 active carry fund investors from 87 countries.
Carlyle Group trades on the NASDAQ stock market under the symbol CG.
As of December 19, 2025, CG stock price climbed to $59.54 with 2,847,796 million shares trading.
CG has a beta of 1.92, meaning it tends to be more sensitive to market movements. CG has a correlation of 0.63 to the broad based SPY ETF.
CG has a market cap of $21.46 billion. This is considered a Large Cap stock.
Last quarter Carlyle Group reported $782 million in Revenue and $.96 earnings per share. This fell short of revenue expectation by $-182 million and missed earnings estimates by -$.05.
In the last 3 years, CG traded as high as $69.85 and as low as $25.20.
The top ETF exchange traded funds that CG belongs to (by Net Assets): IJH, VTI, VB, VBR, VXF.
CG has outperformed the market in the last year with a price return of +24.3% while the SPY ETF gained +18.1%. However, in the short term, CG had mixed performance relative to the market. It has underperformed in the last 3 months, returning -12.1% vs +2.8% return in SPY. But in the last 2 weeks, CG shares have fared better than the market returning +4.3% compared to SPY -0.5%.
CG support price is $57.45 and resistance is $60.25 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CG shares will trade within this expected range on the day.